Barbara Vanderhyden
PhD
Senior Scientist, Cancer Research
Ottawa Hospital Research Institute
Corinne Boyer Chair in Ovarian Cancer Research
University of Ottawa
Distinguished Professor, Cellular and Molecular Medicine
University of Ottawa
Contact
613-737-7700 ext. 70330
501 Smyth Road, Box 926, Ottawa, ON K1H 8L6
Research Groups
Vanderhyden Lab
Bio
Barbara Vanderhyden completed her Ph.D. in Reproductive Physiology at the University of Western Ontario in 1988. She then did postdoctoral studies at The Jackson Laboratory in Maine, where she learned to climb mountains, both literally and scientifically. In 1991, she joined the Cancer Research Group at the University of Ottawa, which has evolved into the Cancer Therapeutics Program at the Ottawa Hospital Research Institute, where she is a Senior Scientist. Dr. Vanderhyden is also a Distinguished University Professor at the University of Ottawa and has held the inaugural Corinne Boyer Chair in Ovarian Cancer Research since 2000. She established and ran the university’s transgenic mouse facility for 14 years. In her spare time, she established two science outreach programs, Let’s Talk Science / Parlons sciences, which makes science fun for students in local schools, and Science Travels / La science voyage, which sends teams of grad students to deliver science workshops in remote First Nations and Inuit communities in the far north.
News
Publications
P53 Mutation Induces Epithelial-to-Mesenchymal Transition (EMT) Associated with Stem Cell Properties and Tumorigenesis in Fallopian Tube Cells
2025-10-01 Go to publicationSox10-Deficient Drug-Resistant Melanoma Cells Are Refractory to Oncolytic RNA Viruses
2023-12-01 Go to publicationUnveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success
2023-12-01 Go to publicationConventional DNA-Damaging Cancer Therapies and Emerging cGAS-STING Activation: A Review and Perspectives Regarding Immunotherapeutic Potential
2023-08-01 Go to publicationPreventing Surgery-Induced NK Cell Dysfunction Using Anti-TGF-β Immunotherapeutics
2022-11-01 Go to publicationRelated Research at The Ottawa Hospital
- Cancer Research Program
- Cancer
- Infertility
- Ovarian cancer
- Women's health
- Discovery research
- Drug development
- Genomics
- Immunotherapy
- Bioinformatics
- Model organisms
- Molecular and cellular biology
- Translational research
- Viral therapy
- Epigenetics
- Transgenic/knockout models
- Disease models
- Gene expression
- Stem cells
- Biomarkers
- Oncolytic viruses
- Cancer biotherapeutics